Fundraising FoxEspervita
3 known investors
Find your way into Espervita
Sign up to see every warm intro you have to Espervita
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Espervita team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.
Founders & leadership
RN
Roger NewtonFounder / Board Advisor
JL
James LallyFounder / Board Advisor
Investors · 3
ID Ventureslisted by ID VenturesDetroit · $50K – $250K
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Michigan Riselisted by Michigan RiseEast Lansing · $50K – $150K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Espervita do?
- Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.
- Who founded Espervita?
- Espervita was founded by Roger Newton, James Lally.
- Who are Espervita's investors?
- Espervita's investors include ID Ventures, Michigan Rise, WMU Biosciences Research & Commercialization Center.